Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.65 HKD | -1.77% | -3.06% | -0.45% |
Apr. 15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
Apr. 15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Neutral |
Resistance | 7.450 | 7.450 | 9.890 |
Spread/Res. | -10.74% | -10.74% | -32.76% |
Spread/Supp. | +13.87% | +13.87% | +39.12% |
Support | 5.840 | 5.840 | 4.780 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 1477 Stock
- Charts Ocumension Therapeutics